DAY ONE BIOPHARMACEUTICALS, INC.: net_income
| Value | {"amount": -142181000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | DAY ONE BIOPHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:35:13.782524+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8e6c97d2-0ff8-442d-8638-f41f27b4ba3e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-026654Retrieved: 2026-08-19T18:35:13.782524+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001845337/net-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8e6c97d2-0ff8-442d-8638-f41f27b4ba3e
History
- supersedes {"amount": -142181000000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001193125-26-161471)